STOCK TITAN

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Akoya Biosciences, Inc. (Nasdaq: AKYA) has announced that it will release its second-quarter financial results on August 8, 2022, after market close. A conference call for investors will take place at 5:00 p.m. ET to discuss these results. Investors can register for the call online and access a webcast on the company’s investor relations website. Akoya specializes in spatial phenotyping, providing advanced single-cell imaging solutions to enhance research in biology and health.

Positive
  • Scheduled release of second-quarter financial results may indicate ongoing business operations.
  • Host a conference call which shows transparency and engagement with investors.
Negative
  • None.

MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the second quarter of 2022 after the market close on Monday, August 8th, 2022. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com 

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com 


FAQ

When will Akoya release its financial results for the second quarter of 2022?

Akoya will release its financial results on August 8, 2022, after market close.

What time is Akoya's conference call regarding its financial results?

The conference call is scheduled for 5:00 p.m. ET on August 8, 2022.

How can investors participate in Akoya's conference call?

Investors can register online to participate in Akoya's conference call.

What is Akoya Biosciences' focus area?

Akoya specializes in spatial phenotyping and provides single-cell imaging solutions.

Akoya BioSciences, Inc.

NASDAQ:AKYA

AKYA Rankings

AKYA Latest News

AKYA Stock Data

117.96M
25.62M
11.09%
70.19%
3.24%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
MARLBOROUGH